Holen Sie sich die Stockscreener-App
1.58
1.28%
0.02
Handel nachbörslich:
1.61
0.03
+1.90%
Schlusskurs vom Vortag:
$1.56
Offen:
$1.54
24-Stunden-Volumen:
969.99K
Relative Volume:
0.76
Marktkapitalisierung:
$302.88M
Einnahmen:
$156.37M
Nettoeinkommen (Verlust:
$-37.49M
KGV:
-7.5238
EPS:
-0.21
Netto-Cashflow:
$-47.77M
1W Leistung:
-1.25%
1M Leistung:
+28.46%
6M Leistung:
+16.18%
1J Leistung:
-16.40%
1-Tages-Spanne:
$1.50
$1.58
1-Wochen-Bereich:
$1.50
$1.70
52-Wochen-Spanne:
$1.12
$2.235
Cerus Corp Stock (CERS) Company Profile
Firmenname
Cerus Corp
Sektor
Branche
Telefon
(925) 288-6000
Adresse
1220 CONCORD AVENUE, CONCORD, CA
Vergleichen Sie CERS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.58 | 299.05M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
133.27 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
370.00 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.54 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.36 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-12 | Eingeleitet | Craig Hallum | Buy |
| 2023-01-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-01-17 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-02-26 | Eingeleitet | BTIG Research | Buy |
| 2019-11-13 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-08-28 | Eingeleitet | Stifel | Buy |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-12-08 | Fortgesetzt | BTIG Research | Neutral |
| 2016-07-07 | Fortgesetzt | Cantor Fitzgerald | Buy |
| 2015-12-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2014-05-02 | Bestätigt | MLV & Co | Buy |
| 2013-04-24 | Bestätigt | Cantor Fitzgerald | Buy |
| 2013-03-15 | Bestätigt | MLV & Co | Buy |
| 2012-04-17 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2012-02-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | Bestätigt | MLV & Co | Buy |
| 2011-06-03 | Eingeleitet | Wedbush | Outperform |
| 2011-03-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | Hochstufung | Avondale | Mkt Perform → Mkt Outperform |
Alle ansehen
Cerus Corp Aktie (CERS) Neueste Nachrichten
What does recent volatility data suggest for Cerus CorporationWeekly Gains Summary & Smart Money Movement Alerts - newser.com
Backtesting results for Cerus Corporation trading strategiesPortfolio Growth Summary & Weekly Sector Rotation Insights - newser.com
Why Cerus Corporation stock is popular among millennialsSwing Trade & Long-Term Safe Investment Ideas - newser.com
What’s the recovery path for long term holders of Cerus Corporation2025 Performance Recap & Risk Controlled Daily Plans - newser.com
Signal strength of Cerus Corporation stock in tech scannersChart Signals & Consistent Profit Alerts - newser.com
Is Cerus Corporation stock a buy for dividend growthWeekly Gains Summary & High Win Rate Trade Alerts - newser.com
Can Cerus Corporation stock hit record highs againWeekly Trend Summary & Safe Capital Growth Plans - newser.com
Live market analysis of Cerus CorporationJuly 2025 Rallies & AI Driven Stock Reports - newser.com
Will a bounce in Cerus Corporation offer an exitQuarterly Market Review & Real-Time Volume Trigger Notifications - newser.com
Wealth Enhancement Advisory Services LLC Acquires 27,092 Shares of Cerus Corporation $CERS - Defense World
What is the fair value estimate for Cerus Corporation (CU2) stock in 20252025 Price Targets & Free Verified High Yield Trade Plans - newser.com
Cerus Corporation stock trend forecastJuly 2025 Levels & Verified Chart Pattern Trade Signals - newser.com
What indicators show strength in Cerus CorporationMarket Trend Review & High Conviction Buy Zone Picks - newser.com
Can a trend reversal in Cerus Corporation lead to recoveryQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
Visualizing Cerus Corporation stock with heatmapsWeekly Gains Report & Verified Momentum Stock Alerts - newser.com
Weiss Ratings Reaffirms Sell (E+) Rating for Cerus (NASDAQ:CERS) - MarketBeat
Cerus Corporation (NASDAQ:CERS) Short Interest Update - MarketBeat
What Fibonacci levels say about Cerus Corporation reboundJuly 2025 Weekly Recap & Low Risk Investment Opportunities - newser.com
Can Cerus Corporation stock sustain market leadershipQuarterly Profit Summary & Short-Term Trading Alerts - newser.com
Cerus (NASDAQ:CERS) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Cerus (NASDAQ:CERS) Share Price Crosses Above 200 Day Moving AverageWhat's Next? - MarketBeat
Will Cerus Corporation stock recover after recent drop2025 Fundamental Recap & AI Powered Trade Plan Recommendations - newser.com
What analysts say about Cerus Corporation CU2 stockCup and Handle Formations & Free Stay Ahead With Picks - earlytimes.in
What momentum indicators show for Cerus Corporation stockJuly 2025 Movers & Real-Time Volume Analysis - newser.com
Finanzdaten der Cerus Corp-Aktie (CERS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cerus Corp-Aktie (CERS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
783,294 |
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
1.19%
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):